Transcriptome Analysis Reveals Anti-Cancer Effects of Isorhapontigenin (ISO) on Highly Invasive Human T24 Bladder Cancer Cells
International Journal of Molecular Sciences · 2024
DOI: 10.3390/ijms25031783 ↗Kurz gefasst
Fachartikel in der Zeitschrift International Journal of Molecular Sciences, 2024. Verfasst von Alex H Li und 7 weiteren Autor:innen. Beteiligte Einrichtung: Division of Environmental Medicine, Department of Medicine, NYU Grossman School of Medicine, 341 East 25th Street, New York, NY 10010, USA. Hauptthemen laut MEDLINE: Urinary Bladder Neoplasms, Stilbenes. Die Arbeit wurde bisher 5-mal zitiert (Crossref) und nennt 111 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: NCI NIH HHS, NIEHS NIH HHS, NIH.
Abstract (Originalsprache)
Bladder cancer, the most common malignancy of the urinary tract, has a poor overall survival rate when the tumor becomes muscle invasive. The discovery and evaluation of new alternative medications targeting high-grade muscle invasive bladder cancer (MIBC) are of tremendous importance in reducing bladder cancer mortality. Isorhapontigenin (ISO), a stilbene derivative from the Chinese herb Gnetum cleistostachyum, exhibits a strong anti-cancer effect on MIBCs. Here, we report the whole transcriptome profiling of ISO-treated human bladder cancer T24 cells. A total of 1047 differentially expressed genes (DEGs) were identified, including 596 downregulated and 451 upregulated genes. Functional annotation and pathway analysis revealed that ISO treatment induced massive changes in gene expression associated with cell movement, migration, invasion, metabolism, proliferation, and angiogenesis. Additionally, ISO treatment-activated genes involved in the inflammatory response but repressed genes involved in hypoxia signaling, glycolysis, the actin cytoskeleton, and the tumor microenvironment. In summary, our whole transcriptome analysis demonstrated a shift in metabolism and altered actin cytoskeleton in ISO-treated T24 cells, which subsequently contribute to tumor microenvironment remodeling that suppresses tumor growth and progression.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Division of Environmental Medicine, Department of Medicine, NYU Grossman School of Medicine, 341 East 25th Street, New York, NY 10010, USA.
ORCID-Profile: Hong Sun
Förderung
- NCI NIH HHS
- NIEHS NIH HHS
- NIH
Zitieren
APA
Li, A. H., Park, S. Y., Li, P., Zhou, C., Kluz, T., Li, J., Costa, M., & Sun, H. (2024). Transcriptome Analysis Reveals Anti-Cancer Effects of Isorhapontigenin (ISO) on Highly Invasive Human T24 Bladder Cancer Cells. International Journal of Molecular Sciences. https://doi.org/10.3390/ijms25031783
Vancouver
Li AH, Park SY, Li P, Zhou C, Kluz T, Li J, et al. Transcriptome Analysis Reveals Anti-Cancer Effects of Isorhapontigenin (ISO) on Highly Invasive Human T24 Bladder Cancer Cells. International Journal of Molecular Sciences. 2024. doi:10.3390/ijms25031783
BibTeX
@article{Li2024,
author = {Li, Alex H and Park, Sun Young and Li, Peiwei and Zhou, Chaoting and Kluz, Thomas and Li, Jingxia and Costa, Max and Sun, Hong},
title = {Transcriptome Analysis Reveals Anti-Cancer Effects of Isorhapontigenin (ISO) on Highly Invasive Human T24 Bladder Cancer Cells},
journal = {International Journal of Molecular Sciences},
year = {2024},
doi = {10.3390/ijms25031783}
}
EUVIMED